VoiceMed, founded in 2020 and headquartered in Italy, is spearheading innovation in the healthcare sector by utilizing advanced AI technology. The company specializes in developing voice-based biomarkers, focusing on enhancing lung and cardiorespiratory health through purely software-based health checks.
Their mission, encapsulated by the slogan "Vocal biomarker for a more proactive healthcare system worldwide," aims to revolutionize healthcare by making it more accessible, accurate, and non-invasive through voice analysis. Such a pioneering approach not only democratizes access to health monitoring but also aligns with the industry's shift towards preventive care.
In its latest financial stride, VoiceMed received a €225.00K Pre Seed Round investment on 25 July 2024 from EIT Digital and Padda Health. This funding recognizes the potential of their AI-driven solutions in transforming healthcare delivery on a global scale.